Poor Sleep Quality Is Associated with Dawn Phenomenon and Impaired Circadian Clock Gene Expression in Subjects with Type 2 Diabetes Mellitus

Abstract EN

Aims.

We investigated whether poor sleep quality is associated with both dawn phenomenon and impaired circadian clock gene expression in subjects with diabetes.

Methods.

81 subjects with diabetes on continuous glucose monitoring were divided into two groups according to the Pittsburgh Sleep Quality Index.

The magnitude of dawn phenomenon was quantified by its increment from nocturnal nadir to prebreakfast.

Peripheral leucocytes were sampled from 81 subjects with diabetes and 28 normal controls at 09:00.

Transcript levels of circadian clock genes (BMAL1, PER1, PER2, and PER3) were determined by real-time quantitative polymerase chain reaction.

Results.

The levels of HbA1c and fasting glucose and the magnitude of dawn phenomenon were significantly higher in the diabetes group with poor sleep quality than that with good sleep quality.

Peripheral leucocytes from subjects with poor sleep quality expressed significantly lower transcript levels of BMAL1 and PER1 compared with those with good sleep quality.

Poor sleep quality was significantly correlated with magnitude of dawn phenomenon.

Multiple linear regression showed that sleep quality and PER1 were significantly independently correlated with dawn phenomenon.

Conclusions.

Dawn phenomenon is associated with sleep quality.

Furthermore, mRNA expression of circadian clock genes is dampened in peripheral leucocytes of subjects with poor sleep quality.